|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Atlas Venture Raises $265 Million Fund, Touts Turnaround From Bloated Years
5/2/2013 8:29:04 AM
Staying up-to-date has never been simpler. Sign up for the free
GenePool newsletter today!
Atlas Venture, a Cambridge, MA-based venture capital firm that focuses on early stage tech and biotech companies, has raised a new $265 million fund after several years of reinventing itself into a leaner, more nimble operation. The news comes on the heels of Boston-area VC firms closing new funds—$650 million for Battery Ventures, $516 million for Third Rock Ventures, and $450 million for Spark Capital—even as the broader VC sector continues to contract around a smaller number of players. Atlas partner Jeff Fagnan, in an interview with Fortune, says a major part of Atlas’ change in focus came from zeroing in on Boston-area startups (along with a few bets in the San Francisco Bay Area, of course). Fortune was the first to report the news.
Help employers find you! Check out all the jobs and post your resume.
|
|
|
|
|
|
|
|
|
|
|